Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Defiance Next Gen Altered Experience ETF
(NY:
PSY
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EDT, Aug 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Defiance Next Gen Altered Experience ETF
With EFT Defiance Psychedelics Fund Closing, Let's Take A Look At Market Movement
August 11, 2022
The fund owning the Defiance Next Gen Altered Experience ETF (NYSEARCA: PSY) and Defiance Next Gen SPAC Derived ETF funds, ETF Series Solutions recently decided to close and liquidate each fund.
Via
Benzinga
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
December 30, 2021
Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous opportunity for inv...
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
The New Defiance "Psychedelic" ETF Is Not What It Is Purported To Be
June 11, 2021
The supposedly first and, supposedly, a
Via
Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
September 21, 2021
We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.
Via
Talk Markets
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
September 20, 2021
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares
Via
Benzinga
Which Psychedelic Stock ETF Is Right For You?
September 18, 2021
This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.
Via
Talk Markets
Want Quick Exposure To The Psychedelics Sector? Check Out This New Active ETF
September 17, 2021
Retail investors are getting new tools for gaining exposure to the
Via
Benzinga
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
First Look ETF: Analyzing New ETFs that use Machine Learning and Tackle Mental Health
July 26, 2021
Stephanie Stanton examines new ETFs that use machine learning to select stocks, tackle new approaches to mental health, and invest in the rebounding hotel and travel industry.
Via
Talk Markets
The 6 Leading Psychedelic Stocks In Drug R&D
July 07, 2021
Drug R&D in the emerging psychedelic drug industry continues to advance. Share prices continue to lag. Here's a comparison of the strengths and weaknesses of six of the leaders in psychedelic drug R&D...
Via
Talk Markets
A New Psychedelics Stocks ETF Just Launched: Here's Why It's Important
June 22, 2021
Psychedelics stocks might not fly beneath the radar for much longer.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Psyched: First Psychedelics ETF Comes To The US, Bills Move Forward In Texas, California and New York
June 07, 2021
Psychedelics ETFs Are Gaining Traction Defiance ETFs launched the “Next Gen Altered Experience ETF,” the ...
Via
Benzinga
Why Seelos Therapeutics Stock Is Jumping Today
June 01, 2021
The company has been included in the first U.S. psychedelics-focused ETF.
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.